Lotemax SM Now Available for Post-Op Ocular Pain and Inflammation

Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38% has been made available by Bausch + Lomb for the treatment of postoperative inflammation and pain following ocular surgery.

Lotemax SM is supplied as a sterile preserved ophthalmic gel containing 3.8mg of loteprednol etabonate, a corticosteroid, per gram of gel. According to the Company, the formulation allows for 2 times greater penetration to the aqueous humor due to the submicron particle size. The SubMicron technology allows for less frequent application when compared with Lotemax Gel.

Regarding administration, the prescribing information states that the bottle should be inverted and shaken once in order to fill the tip before instilling drops. Lotemax SM is available as 5g in a 10mL bottle.

For more information visit bauschhealth.com.